Back to Agenda
BRINGING CLINICAL AND REGULATORY TOGETHER
Speaker(s)
Marta Arias-Salgado
Executive Director; Global Clinical Trial Operation, Merck Sharp & Dohme, Netherlands
Karen Roy, MPHARM
Chief Strategy Officer, Phlexglobal, United Kingdom
Peter Schueler, DrMed, MD
Senior Vice President, Drug Development Neurosciences, ICON plc (CRO), Germany
Hans van Bruggen, MSC
Director of Regulatory Affairs, Celegence, United States
Have an account?
